MSF continued to run tuberculosis (TB), mental health and cardiac care programmes in Chechnya.
For many years, MSF has been working closely with the Chechen Ministry of Health, to implement a TB treatment programme. After handing over the management of multidrug-resistant TB (MDR-TB) treatment to the ministry, MSF focused on extensively drug-resistant TB (XDR-TB), a type of TB that is resistant to second-line drugs. MSF procured appropriate medicines, including new and repurposed drugs, to provide regimens that are more effective than the conventional treatment for patients with XDR-TB. The TB programme also includes laboratory support, health promotion and psychosocial assistance for patients and their families.
In 2016, MSF continued to care for TB patients with diabetes co-morbidity, regularly monitoring their blood sugar and adjusting their treatment as required, and helping them to manage their condition. A total of 60 patients with diabetes and TB, and 79 patients with XDR-TB, were under treatment in December 2016.
In 2016, teams provided individual psychosocial care for 4,838 patients and 314 group counselling sessions for victims of violence in the mental health programme.
Cardiac care in Chechnya
MSF continued to support cardiac care in the emergency hospital in the capital, Grozny, and in Urus-Martan hospital, by supplying drugs and medical equipment and improving the quality of care for acute patients. A masterclass was organised with specialists from the Medical University of Dusseldorf to enhance the technical skills of the Grozny interventional cardiology team. The focus was on angiography (an imaging technique to examine the inside of coronary arteries) and angioplasty (a procedure to widen narrowed or obstructed coronary arteries).
In 2016, the cardiac resuscitation unit admitted 1,327 acute patients, 413 of whom benefited from an angiography, and 397 from an angioplasty.
Year MSF first worked in the country: 1992.
|Individual and group mental health consultations||4,800|
|No. staff in 2016||129|
|2016 Expenditure||€4.9 million|
- Access to essential medicineApply Access to essential medicine filter (8)
- Access to healthcareApply Access to healthcare filter (1)
- Child healthApply Child health filter (7)
- Mental healthApply Mental health filter (11)
- MigrantApply Migrant filter (5)
- Mobile clinicApply Mobile clinic filter (2)
- Refugees and IDPsApply Refugees and IDPs filter (5)
- Sexual violenceApply Sexual violence filter (3)
- Speaking outApply Speaking out filter (2)
- Extensively drug-resistant tuberculosis (XDR-TB)Apply Extensively drug-resistant tuberculosis (XDR-TB) filter (3)
- Hepatitis CApply Hepatitis C filter (2)
- HIV/AIDSApply HIV/AIDS filter (4)
- Infectious diseasesApply Infectious diseases filter (14)
- Kala azar (visceral leishmaniasis)Apply Kala azar (visceral leishmaniasis) filter (1)
- LeishmaniasisApply Leishmaniasis filter (1)
- MalariaApply Malaria filter (1)
- MeaslesApply Measles filter (1)
- Multidrug-resistant tuberculosis (MDR-TB)Apply Multidrug-resistant tuberculosis (MDR-TB) filter (5)
- Parasitic diseasesApply Parasitic diseases filter (2)
- TuberculosisApply Tuberculosis filter (12)
- 2017Apply 2017 filter (3)
- 2016Apply 2016 filter (5)
- 2015Apply 2015 filter (4)
- 2014Apply 2014 filter (2)
- 2013Apply 2013 filter (1)
- 2012Apply 2012 filter (1)
- 2011Apply 2011 filter (2)
- 2010Apply 2010 filter (1)
- 2009Apply 2009 filter (1)
- 2008Apply 2008 filter (2)
- 2006Apply 2006 filter (7)
- 2005Apply 2005 filter (3)
- 2004Apply 2004 filter (14)
- 2003Apply 2003 filter (3)
- 2002Apply 2002 filter (7)
- 2001Apply 2001 filter (1)
- 2000Apply 2000 filter (2)
- 1998Apply 1998 filter (2)